Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jun 28, 2024; 30(24): 3022-3035
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3022
Table 1 Main indications for the use of fecal calprotectin and endoscopy in patients with inflammatory bowel disease
Fecal calprotectin
Endoscopy
Differential diagnosis of IBD and irritable bowel syndromeDifferential diagnosis with mimics
Monitoring therapeutic responseEvaluation of disease extension
Monitoring mucosal healingMonitoring therapeutic response
Monitoring histological healingMonitoring mucosal healing
Prediction of disease activity and postoperative recurrenceMonitoring histological healing
Prediction of disease activity and postoperative recurrence
Dysplasia surveillance
Treatment of some complications (e.g., strictures)